Literature DB >> 4557182

Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).

J H ten Veen, T E Feltkamp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4557182      PMCID: PMC1553628     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  23 in total

1.  LUPUS DIATHESIS AND THE HYDRALAZINE SYNDROME.

Authors:  D ALARCON SEGOVIA; J W WORTHINGTON; L E WARD; K G WAKIM
Journal:  N Engl J Med       Date:  1965-03-04       Impact factor: 91.245

2.  Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa.

Authors:  A Breckenridge; C T Dollery; S M Worlledge; E J Holborow; G D Johnson
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

3.  A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism.

Authors:  E J Lappat; M J Cawein
Journal:  Am J Med       Date:  1968-12       Impact factor: 4.965

4.  Autoantibodies related to treatment with chlorthalidone and alpha-methyldopa.

Authors:  T E Feltkamp; E J Mees; M G Nieuwenhuis
Journal:  Acta Med Scand       Date:  1970-03-03

Review 5.  Drug-induced lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Mayo Clin Proc       Date:  1969-09       Impact factor: 7.616

6.  Cryoglobulins in New Zealand Black mice.

Authors:  W Hijmans; H Radema; L van Es; T E Feltkamp; J J van Loghem; O L Schaap
Journal:  Clin Exp Immunol       Date:  1969-02       Impact factor: 4.330

7.  DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice.

Authors:  A D Steinberg; T Pincus; N Talal
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

8.  Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.

Authors:  D Alarcón-Segovia; E Fishbein; V M Betancourt
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

9.  Systemic lupus erythematosus in a family.

Authors:  W Hift; K C Watson
Journal:  S Afr Med J       Date:  1968-08-17

10.  Antibodies to polynucleotides: distribution in human serums.

Authors:  D Koffler; R I Carr; V Agnello; T Fiezi; H G Kunkel
Journal:  Science       Date:  1969-12-26       Impact factor: 47.728

View more
  9 in total

Review 1.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

2.  Studies on drug-induced lupus erythematosus in mice. II. Drug-induced smooth muscle and skeletal muscle antibodies.

Authors:  J H ten Veen
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

3.  Studies on drug-induced lupus erythematosus in mice. 3. Renal lesions and splenomegaly in drug-induced lupus erythematosus.

Authors:  T M Feltkamp-Vroom
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

4.  Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus.

Authors:  Lynda Mazari; Meryem Ouarzane; Moncef Zouali
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

5.  Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.

Authors:  Y Yamauchi; A Litwin; L Adams; H Zimmer; E V Hess
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

6.  Cross-reaction of antibodies present in sera of vasectomized mice with human swollen spermheads.

Authors:  T Samuel; P R Crewe; A H Kolk; P Rumke; R D Barnes
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

Review 7.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Induction of anti-nuclear antibodies by mercuric chloride in mice.

Authors:  C J Robinson; A A Abraham; T Balazs
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.

Authors:  A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.